Showing results (531-540 of 733) with videos related to
Sort By:
Pageof 74
Brain : a Journal of Neurology|March 17, 2022
Atypical development of Broca's area in a large family with inherited stutteringDaisy G Y Thompson-Lake, Thomas S Scerri, Susan Block, et al.Biorxiv : the Preprint Server for Biology|May 19, 2023
Long-read sequencing and profiling of RNA-binding proteins reveals the pathogenic mechanism of aberrant splicing of an SCN1A poison exon in epilepsyHannah C Happ, Patricia N Schneider, Jung Hwa Hong, et al.Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.Annals of Neurology|December 10, 2013
Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathyGökce Orhan, Merle Bock, Dorien Schepers, et al.Annals of Neurology|October 21, 2020
Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OSLaure Mazzola, Karen L Oliver, Audrey Labalme, et al.Neurology|October 5, 2021
Hypothalamic Hamartomas: Evolving Understanding and ManagementNathan T Cohen, J Helen Cross, Alexis Arzimanoglou, et al.The Lancet. Neurology|May 7, 2013
Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man studyMark J Cook, Terence J O'Brien, Samuel F Berkovic, et al.Epilepsia|April 20, 2022
A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndromePasquale Striano, Stéphane Auvin, Abigail Collins, et al.Epilepsia|March 12, 2025
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndromeIngrid E Scheffer, Rima Nabbout, Lieven Lagae, et al.Epilepsy Research|November 5, 2016
Mortality in Dravet syndromeMonica S Cooper, Anne Mcintosh, Douglas E Crompton, et al.Pageof 74